What is a substitute for Jakafi? Your Guide to Alternatives
•
4 min read
According to a 2024 article from Medscape, several Janus kinase (JAK) inhibitors beyond Jakafi (ruxolitinib) are now approved for myelofibrosis, creating a broader landscape of therapeutic choices. For those wondering what is a substitute for Jakafi, the answer depends heavily on the specific condition being treated, such as myelofibrosis, polycythemia vera, or graft-versus-host disease (GvHD).
